Open OfferJun 12, 2026, 04:43 PM
Climb Bio Launches $100M ATM Offering with Jefferies
AI Summary
Climb Bio, Inc. entered into an Open Market Sale Agreement with Jefferies LLC to offer and sell up to $100 million of its common stock through an "at the market offering." This new agreement replaces a previous Equity Distribution Agreement with Oppenheimer & Co. Inc. for up to $22.35 million, which was terminated effective June 11, 2026, with no shares sold under it. The new offering provides the company with capital-raising flexibility.
Key Highlights
- Entered $100 million Open Market Sale Agreement with Jefferies LLC.
- May sell common stock through "at the market offering" via Jefferies.
- Jefferies' compensation up to 3.0% of gross sales price.
- Terminated previous $22.35 million Equity Distribution Agreement with Oppenheimer.
- No shares were sold under the Oppenheimer agreement prior to termination.
Price Impact
More from CLYM